Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 23: 1238-1244, 1977;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demacker, P. N.
Right arrow Articles by van 't Laar, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demacker, P. N.
Right arrow Articles by van 't Laar, A.

Clinical Chemistry, Vol 23, 1238-1244, Copyright © 1977 by American Association for Clinical Chemistry

Evaluation of the dual-precipitation method by comparison with the ultracentrifugation method for measurement of lipoproteins in serum

PN Demacker, HE Vos-Janssen, AP Jansen and A van 't Laar

We evaluated the dual-precipitation method for quantitative measurement of lipoproteins as described by Wilson and Spiger [J. Lab. Clin. Med. 82, 473 (1973)] for normo- and hyperlipemic sera, by comparison with the results obtained with ultracentrifugation. If serum with an above- normal triglyceride concentration is analyzed, the very-low-density lipoprotein cholesterol value obtained with the precipitation method is usually too low. For measurement of high-density lipoprotein cholesterol the ultracentrifugation and precipitation procedures give comparable results, but the latter method is preferred because sinking pre-beta-lipoproteins present in the high-density lipoprotein fraction isolated by means of the ultracentrifuge may result in falsely high values for cholesterol in that fraction. Therefore, at least for the determination of very-low-density lipoprotein cholesterol in hyperlipemic serum, the use of an ultracentrifuge remains necessary. Because few laboratories have an ultracentrifuge at their disposal, it seemed important to look at the stability of sera in view of the forwarding of samples. Also, a way of increasing the efficiency of the ultracentrifuge was studied. Sera can be stored for a week at 4 degrees C or for 54 h at room temperature without noticeable effect on lipoprotein values. Moreover, reliable values can be obtained with an ultracentrifugation time of 8 h (0.8 X 10(8) g-min).


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Lipid Res.Home page
T. Sprong, M. G. Netea, P. van der Ley, T. J. G. Verver-Jansen, L. E. H. Jacobs, A. Stalenhoef, J. W. M. van der Meer, and M. van Deuren
Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria
J. Lipid Res., April 1, 2004; 45(4): 742 - 749.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. G. Netea, B. J. Kullberg, P. N. M. Demacker, L. E. H. Jacobs, T. J. G. Verver-Jansen, A. Hijmans, L. H. J. van Tits, J. G. J. Hoenderop, P. H. G. M. Willems, J. W. M. Van der Meer, et al.
Native LDL potentiate TNF{alpha} and IL-8 production by human mononuclear cells
J. Lipid Res., July 1, 2002; 43(7): 1065 - 1071.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
B. de Roos, M. J Caslake, A. F. Stalenhoef, D. Bedford, P. N. Demacker, M. B Katan, and C. J Packard
The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects
Am. J. Clinical Nutrition, January 1, 2001; 73(1): 45 - 52.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. G. Netea, N. de Bont, P. N. M. Demacker, B. J. Kullberg, L. E. H. Jacobs, T. J. G. Verver-Jansen, A. F. H. Stalenhoef, and J. W. M. Van der Meer
Lipoprotein(a) Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production by Human Mononuclear Cells
Infect. Immun., May 1, 1998; 66(5): 2365 - 2367.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Huang, S. W. Schwendner, S. C. Rall Jr., D. A. Sanan, and R. W. Mahley
Apolipoprotein E2 Transgenic Rabbits. MODULATION OF THE TYPE III HYPERLIPOPROTEINEMIC PHENOTYPE BY ESTROGEN AND OCCURRENCE OF SPONTANEOUS ATHEROSCLEROSIS
J. Biol. Chem., September 5, 1997; 272(36): 22685 - 22694.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1977 by the American Association for Clinical Chemistry.